XALKORI 200 mg (CRIZOTINIB) QT Prolongation Risk & TQT Data

XALKORI 200 mg

✓ VERIFIED BY DOCTOR

Active Ingredient: CRIZOTINIB

QTc Interval Status:

prolongation

QTc prolonged at high doses in dogs due to Ca and Na channel antagonism

https://doi.org/10.1016/S1470-2045(22)00221-2, https://doi.org/10.1007/s40264-013-0047-5